scispace - formally typeset
Open AccessJournal ArticleDOI

mTORC1 signaling and regulation of pancreatic β-cell mass

TLDR
It is demonstrated that deletion of Tsc1 in pancreatic β cells results in improved glucose tolerance, hyperinsulinemia and expansion of β-cell mass that persists with aging.
Abstract
The capacity of β cells to expand in response to insulin resistance is a critical factor in the development of type 2 diabetes. Proliferation of β cells is a major component for these adaptive responses in animal models. The extracellular signals responsible for β-cell expansion include growth factors, such as insulin, and nutrients, such as glucose and amino acids. AKT activation is one of the important components linking growth signals to the regulation of β-cell expansion. Downstream of AKT, tuberous sclerosis complex 1 and 2 (TSC1/2) and mechanistic target of rapamycin complex 1 (mTORC1) signaling have emerged as prime candidates in this process, because they integrate signals from growth factors and nutrients. Recent studies demonstrate the importance of mTORC1 signaling in β cells. This review will discuss recent advances in the understanding of how this pathway regulates β-cell mass and present data on the role of TSC1 in modulation of β-cell mass. Herein, we also demonstrate that deletion of Tsc1 ...

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal Article

Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. [Erratum: 2004 Sept. 23, v. 431, no. 7007, p. 485.]

TL;DR: In this article, S6K1-deficient mice are protected against obesity owing to enhanced β-oxidation, but on a high fat diet, levels of glucose and free fatty acids still rise in S6k1-dependent mice, resulting in insulin receptor desensitization.
Journal ArticleDOI

The emerging multiple roles of nuclear Akt

TL;DR: Evidence accumulated over the past 15 years has highlighted the presence of active Akt in the nucleus, where it acts as a fundamental component of key signaling pathways, and the most relevant findings about nuclear Akt are summarized.
Journal ArticleDOI

Insulin demand regulates β cell number via the unfolded protein response

TL;DR: A stem cell-independent model of tissue homeostasis is defined, in which differentiated secretory cells use the UPR sensor to adapt organ size to meet demand, suggesting that therapeutic UPR modulation has potential to expand β cell mass in people at risk for diabetes.
Journal ArticleDOI

mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells.

TL;DR: It is suggested that mTORC1 may act as a "double edge sword" in the regulation of β cell mass and function in response to metabolic stress such as nutrient overload and insulin resistance.
Journal ArticleDOI

Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver Disease

TL;DR: Molecular studies in the NAFLD support a key role for PTEN in hepatic insulin sensitivity and the development of steatosis, steatohepatitis, and fibrosis, and review recent studies on the features of the PTEN and the PI3K/AKT pathway.
References
More filters
Journal ArticleDOI

Amino Acid and Insulin Signaling via the mTOR/p70 S6 Kinase Pathway A NEGATIVE FEEDBACK MECHANISM LEADING TO INSULIN RESISTANCE IN SKELETAL MUSCLE CELLS

TL;DR: The mTOR/p70 S6 kinase signaling pathway is identified as a novel modulator of insulin-stimulated glucose transport in skeletal muscle cells.
Journal ArticleDOI

The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity

TL;DR: It is demonstrated that the p90 ribosomal protein S6 kinase (RSK) phosphorylates eIF4B on the same residue as the S6K and RSK proteins, which increases the interaction of eif4B with the eukaryotic translation initiation factor 3.
Journal ArticleDOI

Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR

TL;DR: In this paper, TSC1/Tsc2 does not bind directly to mTOR, nor does it directly influence mTOR kinase activity or cellular phosphatase activity.
Journal ArticleDOI

Balancing Akt with S6K implications for both metabolic diseases and tumorigenesis

TL;DR: These findings form a novel basis for improved understanding of the pathophysiology of metabolic diseases (e.g., diabetes and obesity), tumor syndromes, and human cancers.
Journal ArticleDOI

Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases

TL;DR: It is proposed that eIF4B may mediate some of the effects of the S6Ks on translation, and specifically phosphorylation of Ser422, located in an RNA‐binding region required for eif4A helicase‐promoting activity.
Related Papers (5)